ClinicalPath

A point-of-care reference solution for oncologists

Request a demo

ClinicalPath is a point-of-care reference solution offering evidence-based, clinical pathways for multiple disease scenarios.

With the oncology treatment arena becoming increasingly complex, ClinicalPath works to synthesize the most current medical evidence and expert knowledge, delivering treatment plan options that aim to embody an exceptional standard of care.


What's in ClinicalPath?

ClinicalPath pathways

Expert defined evidence-based care maps covering medical and radiation oncology

Software portal

Delivering defined cancer pathways in a point-of-care reference solution


ClinicalPath content

Pathways are collaboratively developed by the physicians from within the ClinicalPath network and led by academic and community-based co-chairs. These disease committees meet regularly to review the Pathways for newly published data, updating content four times a year.

Elsevier ClinicalPath covers over 97% of all cancer types and 80% of disease scenarios within a given cancer type 1

Delivers treatment options based on a cancer’s staging and disease characteristics.

Download the brochure

Why ClinicalPath?

Use ClinicalPath to help confirm treatment options for common cancers or help select treatment options for lesser seen presentations.


Helps to reduce variability and to encourage consistency of evidence-based practice amongst physicians


Fast and easy access to defined cancer pathways tailored to disease stage and characteristics


Supports precision medicine by helping to encourage oncologists to order appropriate bio markers and genetic screening panels.


Can act as a learning aid for an inter-professional cancer care teams, simulating disease scenarios and providing information on treatment options.


Can help save time, researching treatment options for more complex disease scenarios and helps reduce pressure to stay current


(1) Pathway coverage is determined by comparing disease states covered by ClinicalPath vs. cancer incidence rates in the US (from SEER data https://seer.cancer.gov/statistics/). The On-Pathway rate is calculated by the reporting group of customers in the US where ClinicalPath is integrated into the EMR, based on the network utilization data set (actual physician clicks during navigations), and on average is ~80%. Meaning that > 80% of the time navigating physicians are finding the appropriate treatment for their patients’ particular presentation.